Cartesian Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.

About RNAC

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases.

CEO

Carsten Brunn

CEOCarsten Brunn

Employees

—

Employees—

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

Employees

—

Employees—

RNAC Key Statistics

Market cap

267.85M

Market cap267.85M

Price-Earnings ratio

-0.19

Price-Earnings ratio-0.19

Dividend yield

—

Dividend yield—

Average volume

87.22K

Average volume87.22K

High today

$10.53

High today$10.53

Low today

$10.11

Low today$10.11

Open price

$10.40

Open price$10.40

Volume

41.43K

Volume41.43K

52 Week high

$41.87

52 Week high$41.87

52 Week low

$8.85

52 Week low$8.85

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

People also own

Based on the portfolios of people who own RNAC. This list is generated using Robinhood data, and it’s not a recommendation.